Примери за използване на Combination with dabrafenib на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Cases of cuSCC(including keratoacanthoma) have been reported in patients treated with trametinib in combination with dabrafenib.
Hepatic adverse reactions have been reported in clinical trials with trametinib as monotherapy and in combination with dabrafenib.
when used in combination with dabrafenib.
Pulmonary embolism or deep vein thrombosis can occur when trametinib is used as monotherapy or in combination with dabrafenib.
RVO, may occur with trametinib as monotherapy and in combination with dabrafenib.
The usual dose of Mekinist either used alone or in combination with dabrafenib is one 2 mg tablet once a day.
whether used as monotherapy or in combination with dabrafenib.
occurred in patients taking trametinib as monotherapy and in combination with dabrafenib.
Hepatic adverse reactions have been reported in clinical trials with trametinib as monotherapy and in combination with dabrafenib(see section 4.8).
In patients receiving trametinib in combination with dabrafenib, there have been occasional reports of acute,
In the Phase III study MEK115306 no patients treated with trametinib in combination with dabrafenib had worst-case QTcB prolongation to>500 msec;
whether given as monotherapy or in combination with dabrafenib, should be permanently discontinued.
Elevations in blood pressure have been reported in association with trametinib as monotherapy and in combination with dabrafenib, in patients with or without pre-existing hypertension.
treated with trametinib in combination with dabrafenib had a QTcB Grade 3 increase(> 500 msec).
have been reported in patients taking trametinib as monotherapy and in combination with dabrafenib(see section 4.8).
Up to 3 in 100 people taking Mekinist in combination with dabrafenib may develop a different type of skin cancer called cutaneous squamous cell carcinoma(cuSCC).
have occurred in patients taking trametinib as monotherapy and in combination with dabrafenib(see section 4.8).
Elevations in blood pressure have been reported in association with trametinib as monotherapy and in combination with dabrafenib, in patients with or without pre-existing hypertension(see section 4.8).
Mekinist, or the combination with dabrafenib, can cause problems with your liver which may develop into serious conditions such as hepatitis
In patients receiving trametinib in combination with dabrafenib, pyrexia may be accompanied by severe rigors,